# GOREISAN for Heart Failure (GOREISAN-HF) Trial

> **NCT04691700** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Takeshi Morimoto** · enrollment: 1179 (actual)

## Conditions studied

- Heart Failure
- Edema
- Traditional Japanese Medicine
- Kampo Medicine
- Clinical Trial

## Interventions

- **DRUG:** Goreisan
- **DRUG:** Standard Treatment

## Key facts

- **NCT ID:** NCT04691700
- **Lead sponsor:** Takeshi Morimoto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-01-19
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 1179 (ACTUAL)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04691700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04691700, "GOREISAN for Heart Failure (GOREISAN-HF) Trial". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT04691700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*